Technology transfer
AstraZeneca has launched the production of the first targeted drug for the treatment of lung cancer – osimertinib at its enterprise in the Kaluga region.
14.09.2017AstraZeneca has launched the production of the first targeted drug for the treatment of lung cancer – osimertinib at its enterprise in the Kaluga region.
14.09.2017An international team of scientists edited the genome of cells of patients with severe immunodeficiency – chronic granulomatosis caused by genetic breakdowns.
12.01.2017An experimental Ebola vaccine tested in African Guinea has shown almost 100% effectiveness, the WHO said.
23.12.2016The opening of a research complex for the development of innovative medicines for advanced therapy based on the BIOCAD laboratory took place in St. Petersburg.
20.06.2016Resembling a hairnet, the "magic hat" uses magnetic impulses to change the nature of the work of certain parts of the brain. With its help, the volunteers demonstrated outstanding results when testing various abilities.
06.10.2008Vaccines based on the patient's own cells are already undergoing clinical trials in patients with cancer, but they will be tested for the first time in rheumatoid arthritis. The experimental stage was very impressive, and scientists expect that the vaccine will be able to specifically suppress the pathological autoimmune response.
02.09.2008The ceremony of awarding the largest (in monetary terms) scientific Breakthrough Prize was held in California.
09.11.2015By controlling the level of the AID enzyme, microRNA-155 regulates the fight of the immune system against microbes, while preventing the formation of very aggressive malignant diseases: leukemia and B-cell lymphomas.
16.06.2008Reagents for the determination of Ebola virus RNA by polymerase chain reaction have been officially registered in Russia.
20.10.2014As a result of the selection of the optimal shape of the surface and the parameters of electrical stimulation, the rate of formation of cartilage tissue based on the new nanofilm was increased by more than three times.
06.06.2008Data processing has shown that the low activity of insulin-like growth factor-1 corresponds to a significantly higher mortality rate than the high activity of this hormone.
28.05.2008Director of the Institute of Gerontology of the Russian Academy of Medical Sciences, Academician of the Russian Academy of Medical Sciences Vladimir Shabalin: "Such sensations appear almost every month. But then it turns out that the sensation quickly "deflated". I am sure that the same thing will happen with the "death indicator"."
13.08.2013The new version of ReMISSION consists of six games designed for psychological assistance to young people suffering from cancer, who have a high risk of an unfavorable outcome.
08.05.2013Selecta (RUS), the Russian division of the Rusnano portfolio company Selecta Biosciences, Inc., synthesized the first batch of tSVP nanoparticles with an active component of an anti-nicotine vaccine.
14.03.2013VEB will finance the construction of a plant for the production of innovative biotechnological drugs "Fort" in the Ryazan region.
21.11.2011The number of stem cell transplants in Russia does not exceed 560 per year, while only among patients with tumors of the hematopoietic system from 7-10 thousand patients need them.
16.03.2011Pharmaceutical corporations advertise new drugs, which often have not passed a sufficient number of clinical trials. 85% of new drugs are ineffective, but they can cause serious harm to health.
23.08.2010Usually, the cell dies within three to four hours after the electrodes are inserted into it. The probe, developed by nanotechnologists from Stanford, increased the life time of the studied cells to a week.
06.04.2010The mobile phone will make sure that the patient takes the pill on time, measure the pressure and pulse and diagnose the patient. Medical firms together with mobile operators are developing new services.
15.02.2010Attempts to cure a patient with a complex open leg fracture complicated by infection failed, and the only alternative to amputation was experimental treatment with their own stem cells.
17.12.2009You can write to the editor at:
vm@vechnayamolodost.ruThe editors of Eternal Youth are preparing a useful and interesting mailing list. You can get it if you leave your mail.